Nano-C Announces Successful Commercial Production Levels Of Fullerenes - News

Sponsored by Nano-COct 29 2003

Using technology developed by MIT researchers Nano-C, Inc. has announced the successful development of an important new combustion method of fullerenes production. The technology allows fullerenes to be produced by the tonne with a dramatic reduction is cost. This, in turn, means companies can more readily develop applications for the soccer ball shaped carbon molecules in pharmaceuticals, personal care, conducting and commodity polymers.

Since their discovery in 1985, fullerene production has been based on a carbon arc method. This yielded only small, impure quantities that required costly solvent-based separation and puification. The Nano-C patented combustion technology offers greater production rates and purity levels of over 95%.

Posted 27^th October 2003

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

APA
Nano-C. (2013, June 11). Nano-C Announces Successful Commercial Production Levels Of Fullerenes - News. AZoNano. Retrieved on April 24, 2024 from https://www.azonano.com/article.aspx?ArticleID=53.
MLA
Nano-C. "Nano-C Announces Successful Commercial Production Levels Of Fullerenes - News". AZoNano. 24 April 2024. <https://www.azonano.com/article.aspx?ArticleID=53>.
Chicago
Nano-C. "Nano-C Announces Successful Commercial Production Levels Of Fullerenes - News". AZoNano. https://www.azonano.com/article.aspx?ArticleID=53. (accessed April 24, 2024).
Harvard
Nano-C. 2013. Nano-C Announces Successful Commercial Production Levels Of Fullerenes - News. AZoNano, viewed 24 April 2024, https://www.azonano.com/article.aspx?ArticleID=53.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this article?

Leave your feedback

Public Comment

Private Feedback to AZoNano.com

Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.